IMAX Corporation

NYSE:IMAX Lagerbericht

Marktkapitalisierung: US$2.0b

IMAX Management

Management Kriterienprüfungen 3/4

IMAX CEO ist Rich Gelfond , ernannt in May 2026, hat eine Amtszeit von 32.17 Jahren. Die jährliche Gesamtvergütung beträgt $8.66M , bestehend aus 13.9% Gehalt und 86.1% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 1.39% der Aktien des Unternehmens, im Wert von $27.30M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.1 Jahre bzw. 10.9 Jahre.

Wichtige Informationen

Rich Gelfond

Geschäftsführender

US$8.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts13.86%
Amtszeit als Geschäftsführerno data
Eigentum des Geschäftsführers1.4%
Durchschnittliche Amtszeit des Managements5.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder10.9yrs

Jüngste Management Updates

Recent updates

Analyse-Update May 02

IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power

The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.
Analyse-Update Apr 18

IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside

The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.
Analyse-Update Apr 04

IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk

Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.
Analyse-Update Mar 21

IMAX: Record Box Office And Premium Format Position Will Support Future Upside

The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.
Analyse-Update Mar 06

IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk

The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.
Analyse-Update Feb 20

IMAX: Live Sports And Content Partnerships Will Support Future Upside

Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.
Analyse-Update Feb 05

IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities

Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.
Analyse-Update Jan 22

IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential

Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.
Seeking Alpha Jan 09

IMAX Corporation: Strong Network Effect And Visible Growth Ahead

Summary I rate IMAX Corp. a buy, citing strong network effects, visible near-term growth, and a resilient, diversified revenue profile. IMAX's network remains less than 40% penetrated, with over 470 confirmed system orders and a robust blockbuster and local-language content pipeline. The Netflix Narnia partnership signals a strategic shift, potentially expanding IMAX’s content supply beyond traditional studios to major streaming platforms. Consensus estimates appear overly cautious; applying an 11x EBITDA multiple implies ~30% upside from current market cap, with key risks in streaming adoption and China exposure. Read the full article on Seeking Alpha
Analyse-Update Jan 08

IMAX: Premium Screens And Local Language Hits Will Support Future Upside

Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.
Analyse-Update Dec 21

IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance

Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.
Analyse-Update Dec 07

IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance

We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.
Analyse-Update Nov 22

IMAX: Future Box Office Releases And Network Expansion Will Shape Performance

IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.
Analyse-Update Nov 01

IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance

The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.
Analyse-Update Oct 18

North America And Japan Installations Will Strengthen Premium Entertainment

Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.
Analyse-Update Oct 04

North America And Japan Installations Will Strengthen Premium Entertainment

IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.
Analyseartikel Sep 09

Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%

IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
Analyseartikel Aug 04

Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?

IMAX Corporation ( NYSE:IMAX ), is not the largest company out there, but it received a lot of attention from a...
Analyseartikel Jun 13

An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued

Key Insights IMAX's estimated fair value is US$42.15 based on 2 Stage Free Cash Flow to Equity Current share price of...
Analyseartikel May 17

Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher

IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
Analyseartikel May 02

IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear

Shareholders appeared unconcerned with IMAX Corporation's ( NYSE:IMAX ) lackluster earnings report last week. We think...
Analyseartikel Apr 19

Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?

While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it saw significant share price...
Analyseartikel Apr 04

Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Analyseartikel Mar 15

We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Seeking Alpha Mar 09

IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema

Summary IMAX remains the leading choice for premium cinema experiences, generating outsized box office returns despite a small footprint of 1% of total screens. The company’s success in China is encouraging, but future box office results may be dampened due to a lack of new local content. IMAX’s global expansion in local language partnerships could face higher costs and challenges adapting to diverse filmmaking workflows. While financially recovered from the pandemic, IMAX’s growth trajectory appears plateaued, with flat revenue and cash flow projections. Given the overvaluation of IMAX stock, investors should hold and wait for a significant price retracement before considering entry. Read the full article on Seeking Alpha
Analyseartikel Jan 08

Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?

While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it led the NYSE gainers with a...
Seeking Alpha Dec 24

IMAX Corporation: Overseas Growth Opportunities

Summary IMAX Corporation's stock has surged 60% since its June lows, but there has been a notable uptick in insider selling in December. IMAX Corporation has considerable long-term growth opportunities and should benefit from an expected well-received movie slate in 2025. An analysis of IMAX Corporation follows in the paragraphs below. Read the full article on Seeking Alpha
Analyseartikel Dec 10

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Analyseartikel Nov 23

IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Key Insights IMAX's estimated fair value is US$45.02 based on 2 Stage Free Cash Flow to Equity IMAX's US$25.19 share...
Analyseartikel Nov 07

After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

The IMAX Corporation ( NYSE:IMAX ) share price has done very well over the last month, posting an excellent gain of...
Analyseartikel Oct 31

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyseartikel Oct 13

If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Seeking Alpha Oct 10

IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential

Summary IMAX Corporation has a long growth runway in international markets, as the foreign markets' IMAX theater network penetration rate is lower than that for the US. IMAX can achieve higher profit margins in the future with rising top line contribution from alternative content that boosts the company's overall capacity utilization rate. IMAX stock is trading at below 1 times PEG, which implies that it is undervalued relative to its financial improvement potential. Read the full article on Seeking Alpha
Analyseartikel Sep 30

When Should You Buy IMAX Corporation (NYSE:IMAX)?

IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it received a lot of attention from a substantial...
User avatar
Neue Analyse Sep 24

Calculated Global Expansion And Innovative Content Slate Set To Propel Growth

IMAX's strategic expansions and landmark deals in global markets promise substantial revenue growth through new installations and high-profile film releases.
Analyseartikel Aug 23

Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
Seeking Alpha Jul 30

IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings

Summary IMAX Corporation provides technology to movie theaters bringing an immersive experience, in part protecting the company from the rise of digital streaming platforms. After consistent backlog declines, IMAX finally reported great new signings in Q2, providing a great midterm growth outlook with a great new blockbuster movie pipeline. While IMAX's midterm growth outlook is great, the stock already prices in good growth, mitigating a very significant investment opportunity from the upbeat outlook. Read the full article on Seeking Alpha
Analyseartikel Jul 26

Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now

When you see that almost half of the companies in the Entertainment industry in the United States have price-to-sales...
Analyseartikel Jun 19

Is IMAX (NYSE:IMAX) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyseartikel May 22

Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?

IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it saw a decent share price growth of 18% on the...
Seeking Alpha Apr 08

IMAX Corporation: Good Reasons To Be Bullish

Summary IMAX Corporation's short-to-medium term performance is expected to be good, as the company is grabbing a bigger slice of the global box office and gaining recognition from the film industry's players. For the long term, IMAX is actively diversifying into non-film content like events and documentaries to reduce its reliance on movies over time. I view IMAX stock as a good investment candidate, as there are multiple positive factors for the shares. Read the full article on Seeking Alpha
Analyseartikel Mar 01

IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

It's been a pretty great week for IMAX Corporation ( NYSE:IMAX ) shareholders, with its shares surging 13% to US$17.13...

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Rich Gelfond im Vergleich zu den Einnahmen von IMAX verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2026n/an/a

US$37m

Dec 31 2025US$9mUS$1m

US$35m

Sep 30 2025n/an/a

US$40m

Jun 30 2025n/an/a

US$33m

Mar 31 2025n/an/a

US$25m

Dec 31 2024US$8mUS$1m

US$26m

Sep 30 2024n/an/a

US$23m

Jun 30 2024n/an/a

US$21m

Mar 31 2024n/an/a

US$26m

Dec 31 2023US$9mUS$1m

US$25m

Sep 30 2023n/an/a

US$25m

Jun 30 2023n/an/a

US$4m

Mar 31 2023n/an/a

-US$7m

Dec 31 2022US$8mUS$1m

-US$23m

Sep 30 2022n/an/a

-US$15m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$21m

Dec 31 2021US$9mUS$1m

-US$22m

Sep 30 2021n/an/a

-US$54m

Jun 30 2021n/an/a

-US$93m

Mar 31 2021n/an/a

-US$109m

Dec 31 2020US$7mUS$1m

-US$144m

Sep 30 2020n/an/a

-US$104m

Jun 30 2020n/an/a

-US$48m

Mar 31 2020n/an/a

-US$11m

Dec 31 2019US$7mUS$1m

US$47m

Vergütung im Vergleich zum Markt: RichDie Gesamtvergütung ($USD8.66M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD5.52M).

Entschädigung vs. Einkommen: RichDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Rich Gelfond (69 yo)

no data
Amtszeit
US$8,655,929
Vergütung

Mr. Richard Lewis Gelfond, also known as Rich, has been the Chief Executive Officer at IMAX Corporation since April 1, 2009. He serves as the Co-Chief Executive Officer and Co-Chairman of Clarion Capital P...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Richard Gelfond
CEO & Directorno dataUS$8.66m1.39%
$ 27.3m
Natasha Fernandes
Executive VP & CFO4yrsUS$1.70m0.10%
$ 2.0m
Robert Lister
Chief Legal Officer & Senior EVP14.3yrsUS$2.91m0.37%
$ 7.3m
Anne Globe
Chief Marketing Officer2.3yrsUS$2.06m0.034%
$ 662.9k
Mark Welton
President of IMAX Global Theatres14.6yrsUS$2.62m0.31%
$ 6.2m
Jose Zlatar
Senior VP of Finance & Principal Accounting Officer1.1yrskeine Daten0.0020%
$ 38.7k
Heather Anthony
Head of Enterprise Transformation10.3yrskeine Datenkeine Daten
Pablo Calamera
Executive VP & CTO6.3yrskeine Daten0.11%
$ 2.1m
Jennifer Horsley
Senior VP & Head of Investor Relations3.7yrskeine Datenkeine Daten
Mark Jafar
Global Head of Corporate Communications6.9yrskeine Datenkeine Daten
Michele Golden
Executive VP & Chief People Officer3.7yrskeine Daten0.069%
$ 1.3m
Edward MacNeil
Senior Vice President of Finance24.7yrsUS$460.51kkeine Daten
5.1yrs
Durchschnittliche Betriebszugehörigkeit
58yo
Durchschnittliches Alter

Erfahrenes Management: Das Managementteam von IMAX ist erfahren und erfahren (durchschnittliche Amtszeit von 5.1 Jahren).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Richard Gelfond
CEO & Director32.2yrsUS$8.66m1.39%
$ 27.3m
Dana Settle
Independent Director10.8yrsUS$187.48k0.12%
$ 2.3m
Michael I. MacMillan
Independent Director12.9yrsUS$189.98k0.069%
$ 1.4m
Eric Demirian
Independent Director15.7yrsUS$199.98k0.067%
$ 1.3m
Kevin Douglas
Independent Director9.6yrsUS$192.48k13.39%
$ 262.9m
David Leebron
Lead Independent Director22.7yrsUS$199.98k0.23%
$ 4.6m
Darren Throop
Independent Chairman of the Board10.9yrsUS$282.48k0.066%
$ 1.3m
Gail Berman
Independent Director3.2yrsUS$182.48k0.035%
$ 684.9k
Jennifer Wong
Independent Director3.2yrsUS$184.98k0.035%
$ 684.9k
Stephen Pamon
Independent Director4.9yrsUS$187.48k0.058%
$ 1.1m
10.9yrs
Durchschnittliche Betriebszugehörigkeit
64yo
Durchschnittliches Alter

Erfahrener Vorstand: IMAXDie Vorstandsmitglieder sind sehr erfahren ( 10.9 ).


Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/07 17:45
Aktienkurs zum Tagesende2026/05/07 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

IMAX Corporation wird von 20 Analysten beobachtet. 11 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Marla BackerAscendiant Capital Markets LLC
David McFadgenATB Cormark Historical (Cormark Securities)
Patrick ShollBarrington Research Associates, Inc.